← Back to Clinical Trials
Recruiting NCT06692309

NCT06692309 Exploring the Predictive Value of Electroencephalography Features in Perioperative Neurocognitive Disorders Following Cardiovascular Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06692309
Status Recruiting
Phase
Sponsor Beijing Chao Yang Hospital
Condition Cardiovascular Surgery
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2023-03-01
Primary Completion 2025-08-31

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
cardiovascular surgery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2023-03-01 with a primary completion date of 2025-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To explore the predictive value of Electroencephalography features in Perioperative Neurocognitive Disorders in patients undergoing cardiovascular surgery under general anesthesia

Eligibility Criteria

Inclusion Criteria: 1. Written informed consent 2. undergoing coronary artery bypass surgery or valve replacement surgery under general anaesthesia 3. ASA grade: II-IV 4. older than 60 years 5. Able to complete cognitive function tests Exclusion criteria: 1. history of severe neurological diseases and psychiatric diseases 2. history of drug abuse 3. severe hearing or vision impairment 4. preoperative delirium 5. serious adverse reactions such as cardiac arrest and cardiopulmonary resuscitation during surgery 6. patients undergoing secondary surgery in a short period 7. participation in concurrent clinical trials

Contact & Investigator

Central Contact

Changwei Wei, doctor

✉ changwei.wei@ccmu.edu.cn

📞 13810678936

Principal Investigator

Anshi Wu, doctor

PRINCIPAL INVESTIGATOR

Beijing Chao Yang Hospital

Frequently Asked Questions

Who can join the NCT06692309 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Cardiovascular Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06692309 currently recruiting?

Yes, NCT06692309 is actively recruiting participants. Contact the research team at changwei.wei@ccmu.edu.cn for enrollment information.

Where is the NCT06692309 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06692309 clinical trial?

NCT06692309 is sponsored by Beijing Chao Yang Hospital. The principal investigator is Anshi Wu, doctor at Beijing Chao Yang Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology